{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-278679","form_type":"8-K","ticker":"COGT","cik":"0001622229","company_name":"Cogent Biosciences, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.951475+00:00","generated_at":"2026-05-16T20:24:46.792716+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Cogent Biosciences prices 9.7M share offering at $31 and $230M 1.625% convertible notes due 2031 for ~$475M net","bullets":["Equity offering of 9,677,420 shares at $31.00 per share, upsized from $200M, with underwriters exercising over-allotment for additional 1,451,613 shares.","Convertible notes offering of $200M aggregate principal (upsized to $230M) of 1.625% senior notes due 2031, conversion premium ~45% above equity offering price.","Combined net proceeds expected ~$475.3M, to be used to repay $50M term loan and fund development/commercialization of bezuclastinib.","Offerings led by J.P. Morgan, Jefferies, Leerink Partners, and Guggenheim Securities for equity; Jefferies and J.P. Morgan for notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-278679","json":"https://secwatch.observer/filing/0001193125-25-278679.json","markdown":"https://secwatch.observer/filing/0001193125-25-278679.md","text":"https://secwatch.observer/filing/0001193125-25-278679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525278679/0001193125-25-278679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525278679/d46097d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T20:24:46.792716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}